DBV Technologies S.A. (EPA:DBV)
France · Delayed Price · Currency is EUR 2.102
-0.032 (-1.50%)
Nov 12, 2026, 9:25 AM CET
DBV Technologies Market Cap
DBV Technologies has a market cap or net worth of €660.46 million as of November 11, 2026. It is the 11,907th most valuable company in the world and the 165th biggest in France. Its market cap has increased by 51.27% in one year.
Market Cap
660.46M
Enterprise Value
521.14M
Revenue
3.29M
Global Rank
Country Rank
#165 France
PE Ratio
n/a
ChartMarket Cap Chart
Since March 29, 2012, DBV Technologies's market cap has increased from 79.23M to 660.46M, an increase of 733.61%. That is a compound annual growth rate of 15.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 660.46M | -2.60% |
| Dec 31, 2025 | 678.09M | 949.56% |
| Dec 31, 2024 | 64.61M | -63.70% |
| Dec 29, 2023 | 177.98M | -39.80% |
| Dec 30, 2022 | 295.62M | 75.76% |
| Dec 31, 2021 | 168.19M | -29.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nanobiotix | 1.45B |
| MedinCell | 1.08B |
| Inventiva | 786.81M |
| Genfit | 551.34M |
| Valneva SE | 492.38M |
| Valerio Therapeutics Société anonyme | 244.73M |
| Transgene | 201.85M |
| Innate Pharma | 122.37M |